%0 Journal Article
%T Complete Response for More than 4 Years following Neoadjuvant FOLFOX and Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for a Patient with Advanced Gastric Cancer with Extensive Peritoneal Carcinomatosis
%A Carlos Henrique Andrade Teixeira
%A Luciana Rodrigues de Meirelles
%A Pedro Alexandre Ismael Amaral Silva
%A Renata D'Alpino Peixoto
%A Tercia Tarciane de Sousa
%J Archive of "Case Reports in Oncology".
%D 2018
%R 10.1159/000488978
%X Peritoneal carcinomatosis is usually a terminal disease with short median survival in patients with gastric cancer. Systemic FOLFOX is one of the most used regimens in the first-line treatment of metastatic gastric cancer. However, there is scarce evidence that cytoreductive surgery (CRS) and intraperitoneal heated chemotherapy (HIPEC) improves oncological outcomes of patients with advanced gastric cancer
%K Gastric cancer
%K Cytoreductive surgery
%K Intraperitoneal chemotherapy
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006599/